Cardinal Health receives TRO to resume controlled medicine shipments from Lakeland

NewsGuard 100/100 Score
Editorial Checklist Reviewed
Feb 4 2012Cardinal Health, Inc.

Today Cardinal Health was granted a temporary restraining order against the Drug Enforcement Administration's (DEA) immediate suspension order of its Lakeland, Fla. DEA registration.

U.S. District Court for the District of Columbia Judge Reggie B. Walton granted the temporary restraining order that allows Cardinal Health to immediately resume shipments of controlled medicines from its Lakeland facility to hospital and pharmacy customers pending a preliminary injunction hearing currently scheduled for February 13.

Source:

Cardinal Health, Inc.

Posted in: Pharmaceutical News

Tags: , , ,

Comments (0)

Suggested Reading

Study highlights anti-inflammatory properties of herbal medicine, Erigeron breviscapus to treat osteoarthritis
Olive oil – 7 grams per day may keep the dementia away!
Renaissance of "food as medicine" in modern clinical trials
Gut microbiome study challenges established cancer biomarkers, identifies new bacterial links to colorectal cancer
Black cumin: Ancient superseed with modern health benefits
MGI Enters Strategic Partnership with Prepaire Labs to Advance Drug Discovery and Precision Medicine
Repurposed nasal antibiotic neomycin shows promise in preventing and treating respiratory viral infections
Vaping poses unexpected risks to eye health, study finds

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
Balancing efficacy and safety: The challenges of mRNA drugs and vaccines in modern medicine